Ipilimumab vs Lithium Carbonate

## Ipilimumab vs Lithium Carbonate: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Lithium Carbonate**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Lithium Carbonate**: Modulates intracellular signaling via inositol and GSK-3 inhibition.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Lithium Carbonate — 18-36 hours.

## Chemical Properties

**Molecular Formula**: Ipilimumab — N/A; Lithium Carbonate — Li2CO3.

**Molecular Weight**: Ipilimumab — N/A; Lithium Carbonate — 73.8910 g/mol.

**Type**: Ipilimumab — Antibody; Lithium Carbonate — Small molecule.